ARL3 activation requires the co-GEF BART and effector-mediated turnover

  1. Yasmin ElMaghloob
  2. Begoña Sot
  3. Michael J McIlwraith
  4. Esther Garcia
  5. Tamas Yelland
  6. Shehab Ismail  Is a corresponding author
  1. Beatson Institute for Cancer Research, United Kingdom
  2. IMDEA Nanoscience, Spain
1 additional file

Additional files

All additional files

Any figure supplements, source code, source data, videos or supplementary files associated with this article are contained within this zip.

https://cdn.elifesciences.org/articles/64624/elife-64624-supp-v1.zip

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yasmin ElMaghloob
  2. Begoña Sot
  3. Michael J McIlwraith
  4. Esther Garcia
  5. Tamas Yelland
  6. Shehab Ismail
(2021)
ARL3 activation requires the co-GEF BART and effector-mediated turnover
eLife 10:e64624.
https://doi.org/10.7554/eLife.64624